EUVIMEDEUVIMED entdecken
Fallbericht

Successful oral desensitization to temozolomide in a patient with immediate hypersensitivity reaction

Ece Şahinoğlu, Muhittin Akarsu, Selma Yalçın, Dilşad Mungan, Zeynep Celebi Sozener

Cancer Chemotherapy and Pharmacology · 07.07.2026 · 96 (1)

DOI: 10.1007/s00280-026-04922-9 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 07.07.2026. Verfasst von Ece Şahinoğlu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Temozolomide, Desensitization, Immunologic, Antineoplastic Agents, Alkylating, Glioblastoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Temozolomide (TMZ) is an oral alkylating agent that represents a cornerstone therapy for glioblastoma and other high-grade gliomas. Although TMZ is generally well tolerated, hypersensitivity reactions (HSRs), including urticaria, have rarely been reported and may lead to treatment interruption. Rapid drug desensitization (RDD) offers a potential strategy to enable continuation of essential therapy; however, standardized protocols for TMZ are limited. Here, we present a 46-year-old woman with glioblastoma who developed widespread urticaria during maintenance TMZ therapy. The reaction developed within four hours of the last dose and completely resolved following treatment with corticosteroids and antihistamines within 24 h. Based on clinical history and lesion characteristics, an immediate HSR to TMZ was considered. As no alternative treatment options were available, an oral RDD protocol targeting a dose of 240 mg was prepared. The protocol included stepwise dose escalation using diluted oral solutions followed by capsule administration, with premedication using cetirizine and methylprednisolone. Desensitization was successfully completed without breakthrough reactions, and the protocol was repeated in two consecutive cycles without complications. Our protocol provides detailed information on drug preparation, dose increments, and administration intervals, supporting its reproducibility and feasibility. This case contributes to the limited literature by demonstrating that oral RDD can be safely and effectively performed in patients with TMZ-induced urticaria. The successful repetition of desensitization further supports the safety of this approach. This protocol may assist clinicians in maintaining first-line TMZ therapy in patients with HSRs, thereby preventing unnecessary treatment interruptions and improving clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideDesensitization, ImmunologicAntineoplastic Agents, AlkylatingGlioblastomaDrug HypersensitivityHypersensitivity, ImmediateUrticariaHumansFemaleMiddle AgedAdministration, OralBrain Neoplasms

Stichwörter der Autor:innen

Hypersensitivity reactionOral desensitizationRapid drug desensitizationTemozolomideUrticaria

Substanzen

TemozolomideAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Turkey. zeynepsozener@gmail.com.

Zitieren

APA

Şahinoğlu, E., Akarsu, M., Yalçın, S., Mungan, D., & Celebi Sozener, Z. (2026). Successful oral desensitization to temozolomide in a patient with immediate hypersensitivity reaction. Cancer Chemotherapy and Pharmacology, 96(1). https://doi.org/10.1007/s00280-026-04922-9

Vancouver

Şahinoğlu E, Akarsu M, Yalçın S, Mungan D, Celebi Sozener Z. Successful oral desensitization to temozolomide in a patient with immediate hypersensitivity reaction. Cancer Chemotherapy and Pharmacology. 2026;96(1). doi:10.1007/s00280-026-04922-9

BibTeX
@article{ahinolu2026,
  author = {Şahinoğlu, Ece and Akarsu, Muhittin and Yalçın, Selma and Mungan, Dilşad and Celebi Sozener, Zeynep},
  title = {Successful oral desensitization to temozolomide in a patient with immediate hypersensitivity reaction},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2026},
  volume = {96},
  number = {1},
  doi = {10.1007/s00280-026-04922-9}
}
Kostenlos starten →